Methods of treating systemic lupus erythematosus with BTK inhibitors

JP2023550416A5Active Publication Date: 2024-11-27BEIGENE SWITZERLAND GMBH
0 Cites 0 Cited by

Patent Information

Application Number
JP2023530156
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-11-20
Filing Date
2021-11-19
Publication Date
2024-11-27
Estimated Expiration
2041-11-19
Patent Text Reader

Abstract

Provided herein are methods of treating lupus nephritis, particularly systemic lupus erythematosus, including active proliferative lupus nephritis, in a subject with (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo-[1,5-a]pyrimidine-3-carboxamide or a pharmaceutically acceptable salt thereof.
Need to check novelty before this filing date? Find Prior Art